Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-29 @ 4:06 PM
Study NCT ID:
NCT00950768
Status:
COMPLETED
Last Update Posted:
2009-08-03
First Post:
2009-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-02
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-31
First Submit QC Date:
None
Study First Post Date:
2009-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-07-31
Last Update Post Date:
2009-08-03
Last Update Post Date Type:
ESTIMATED